ICDAMT · Registering as Listener

International Conference on Diabetes, Albuminuria Management and Technology

8th Jan – 9th Jan 2027 Chicago, USA Standard / Physical Participation
Listener Registration From
$—
$— in person
Registration Benefits:
Official invitation letterIssued automatically after registration
Certificate & digital materialsGet certificate, slides and resource materials
Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

For Support Please Contact

Coupon code

Have a code? Apply it here — the discount updates the total immediately.

Apply
VISA MC AMEX UPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceICDAMT
ModeStandard / Physical
ParticipationListener
Registration fee$—
Bank charges (5.8%)$—
Discount-$0.00
Total payable $—

Includes all bank processing charges — the amount above is exactly what will be charged. View charge breakdown

Need help?

Contact our registration team:

Benefits of Registering as Listener
Access to Conference Sessions
Networking Opportunities
Certificate of Participation
Invitation Letter Support
Conference Kit / Materials
Access to Keynote Sessions
Conference Session Tracks
SDG Wheel

SDG-Aligned Research Themes

International Conference on Diabetes, Albuminuria Management and Technology conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 2 - Zero Hunger SDG 3 - Good Health and Well-being SDG 4 - Quality Education SDG 9 - Industry, Innovation and Infrastructure

This track focuses on the latest advancements in diabetes management, including novel therapeutic approaches and technologies. Researchers are invited to present their findings on cutting-edge interventions that improve patient outcomes.

This session will explore the complex relationship between diabetes and cancer, highlighting shared risk factors and potential mechanisms. Contributions should address the implications for prevention and treatment strategies.

This track examines the effects of diabetes on cognitive function and brain health. Papers should investigate the underlying mechanisms and potential interventions to mitigate cognitive decline in diabetic patients.

This session will delve into the cardiovascular complications associated with diabetes, including the role of cardiac resynchronization therapy and implantable devices. Presentations should focus on innovative treatment strategies and outcomes.

This track addresses the prevention and treatment of diabetic foot ulcers, a common complication in diabetes. Researchers are encouraged to share their insights on effective management strategies and novel therapeutic approaches.

This session will focus on the impact of food and nutrition on diabetes management. Contributions should explore dietary strategies, including the role of physical activity and yoga therapy in improving glycemic control.

This track investigates the interplay between obesity and diabetes, including the concept of diabesity. Researchers are invited to present methods for prevention and control of diabetes in obese populations.

This session will highlight the application of bioinformatics tools and techniques in diabetes research. Presentations should focus on data-driven insights that enhance understanding and management of diabetes.

This track will explore the epidemiological trends of diabetes among older adults. Contributions should address the unique challenges and management strategies for this demographic.

This session will examine the role of herbs, supplements, and alternative medicines in diabetes management. Researchers are encouraged to present evidence-based findings on their efficacy and safety.

This track focuses on the development and evaluation of new anti-diabetic agents. Presentations should discuss their mechanisms of action, clinical efficacy, and potential impact on diabetes care.

COPYRIGHT © 2026 International Conference on Diabetes, Albuminuria Management and Technology. ALL RIGHTS RESERVED